Cures requires the Food and Drug Administration to evaluate its trial designs and issue guidance for the purposes of 'incorporating complex adaptive and other novel trial designs.'
Michael Burgess: “Cures requires the Food and Drug Administration to evaluate its trial designs and issue guidance for the purposes of…”
Editor's note · Context
Emphasizing the need for FDA to adapt trial designs.
Share
More from Michael Burgess
I reserve the balance of my time. Mr. McGOVERN. Madam Speaker, may I inquire as to how many speakers the gentleman has remaining?
By direction of the Committee on Rules, I call up House Resolution 1486 and ask for its immediate consideration. The Clerk read the resolution, as follows: H. Res. 1486 Resolved, That at any time after adoption of this resolution the…
I am prepared for the gentleman to close. Mr. McGOVERN. Mr. Speaker, I yield myself the balance of my time to close. Mr. Speaker, let us talk about priorities. My Republican colleagues have theirs all screwed up, and I am being really kind…
I thank my friend for yielding. I rise today in support of this very important rule. Specifically, I rise in support of Israel following the attack on Israel by Iran this past weekend. This direct attack on Israel is unprecedented. It does…





